Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research[1].
Molecular Weight:
(142.98 kDa)
Purity:
99
CAS Number:
[2156634-62-5]
Target:
Thrombin,Tissue Factor Pathway Inhibitor (TFPI)
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted